Pengli Li focuses her practice on the representation of public companies and investment banks on capital markets transactions, including initial and follow-on equity and debt offerings. She also advises public companies on SEC compliance and reporting, as well as corporate governance matters.

Download full bio 

Experience

  • Core Scientific to Combine With SPAC Power & Digital Infrastructure Acquisition Corp. 

  • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab 

  • Repare Therapeutics - $253 Million IPO 

  • Datadog – $745 Million IPO 

  • Milestone Pharmaceuticals – $95 Million IPO 

Education

  • Cornell Law School
    JD, 2016

  • The George Washington University
    BA, Political Science
    summa cum laude, 2013


Admissions & Credentials

Massachusetts

New York